Pharmaceutical Business review

Nastech raises $7.93 million in registered offering

Under terms of the agreement, the company will sell 4.58 million shares of its common stock at $1.73 per share. As part of the transaction, the investors also will receive warrants, with a seven-year term, to purchase 4.58 million shares of common stock at an exercise price of $2.38 per share. The warrants will be exercisable beginning October 25, 2008.

In addition, the investors have the right to purchase up to 1,375,578 shares of common stock at a price of $2.17 per share during the 90-day period beginning October 25, 2008. If fully exercised, total gross proceeds would be $2.98 millions. The company plans to use the proceeds of this transaction for working capital.